Zobrazeno 1 - 10
of 37
pro vyhledávání: '"Yohji Itoh"'
Autor:
Michiko Asano, Hiroshi Okada, Yohji Itoh, Hajime Hirata, Kensuke Ishikawa, Erika Yoshida, Akiko Matsui, Elizabeth J. Kelly, Kathryn Shoemaker, Urban Olsson, Johan Vekemans
Publikováno v:
International Journal of Infectious Diseases, Vol 114, Iss , Pp 165-174 (2022)
ABSTRACT: Background: Immunogenicity and safety of the AZD1222 (ChAdOx1 nCoV-19) vaccine was evaluated in Japanese adults in an ongoing phase 1/2, randomized, double-blind, parallel-group, placebo-controlled, multi-centre trial (NCT04568031). Methods
Externí odkaz:
https://doaj.org/article/5a9a99c9026245c48ec517cf46724f79
Autor:
Akihito Yokoyama, Hiroshi Okazaki, Naoyuki Makita, Ayako Fukui, Yi Piao, Yoshifumi Arita, Yohji Itoh, Naoki Tashiro
Publikováno v:
Allergology International, Vol 71, Iss 1, Pp 47-54 (2022)
Background: In Japan, regional differences in asthma mortality have been reported; however, regional differences in asthma exacerbations have not been studied extensively. Therefore, using a health insurance claims database, we investigated the regio
Externí odkaz:
https://doaj.org/article/b7fd09eca9da47c1ab3dde42c5e97962
Autor:
Junichi Shimizu, Katsuhiro Masago, Haruhiro Saito, Kazumi Nishino, Takayasu Kurata, Yohji Itoh, Yoko Yoshimura, Yutaka Yabuki, Hirotoshi Dosaka-Akita
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 12 (2020)
Background: Molecular diagnostic testing is necessary to guide optimal first-line treatment. The number of patients who receive first-line treatment based on biomarker analysis in Japan is unknown. We aimed to determine the proportion of nonsquamous
Externí odkaz:
https://doaj.org/article/6d112c468256484ab90d13d14e14e562
Autor:
Kewu Huang, Yanfei Guo, Jian Kang, Li An, Zeguang Zheng, Lijun Ma, Liping Peng, Hongyang Wang, Rong Su, Yohji Itoh, Chen Wang
Publikováno v:
Therapeutic Advances in Respiratory Disease, Vol 13 (2019)
Background: Patients diagnosed with chronic obstructive pulmonary disease (COPD) in China are commonly prescribed ipratropium plus theophylline (I+T) therapy. Studies have shown that an inhaled corticosteroid (ICS)/long-acting β 2 -agonist (LABA) co
Externí odkaz:
https://doaj.org/article/4d759f5c3b9a481e8bed1cafaabcd7f5
Autor:
Kensuke Ishikawa, Yohji Itoh, Elizabeth J. Kelly, Erika Yoshida, Michiko Asano, Johan Vekemans, Hiroshi Okada, Kathryn Shoemaker, Hajime Hirata, Urban Olsson, Akiko Matsui
Publikováno v:
International Journal of Infectious Diseases
International Journal of Infectious Diseases, Vol 114, Iss, Pp 165-174 (2022)
International Journal of Infectious Diseases, Vol 114, Iss, Pp 165-174 (2022)
Background: Immunogenicity and safety of the AZD1222 (ChAdOx1 nCoV-19) vaccine was evaluated in Japanese adults in an ongoing phase 1/2, randomized, double-blind, parallel-group, placebo-controlled, multi-centre trial (NCT04568031). Methods: Adults (
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aae0a31e0d31c76cdc9333f47ab91abd
https://pubmed.ncbi.nlm.nih.gov/34688944
https://pubmed.ncbi.nlm.nih.gov/34688944
Autor:
Martin Johnson, Haiyi Jiang, Mitsuo Higashimori, Fredrik Nyberg, Weifeng Tang, Helen Tomkinson, Yohji Itoh, Yusuke Tanigawara, Toshio Kawata
Publikováno v:
Cancer Chemotherapy and Pharmacology. 83:849-858
A prospective, multicenter, large-scale cohort with a nested case–control study (NCT00252759) was conducted to identify and quantify risk factors for interstitial lung disease (ILD) in Japanese patients with non-small-cell lung cancer who received
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::53a4f31e1c817ebdaad046736110cb66
https://doi.org/10.1007/s00280-019-03788-4
https://doi.org/10.1007/s00280-019-03788-4
Autor:
Akihito Yokoyama, Yi Piao, Hiroshi Okazaki, Ayako Fukui, Yohji Itoh, Naoki Tashiro, Yoshifumi Arita, Naoyuki Makita
Publikováno v:
Allergology International, Vol 71, Iss 1, Pp 47-54 (2022)
Background In Japan, regional differences in asthma mortality have been reported; however, regional differences in asthma exacerbations have not been studied extensively. Therefore, using a health insurance claims database, we investigated the region
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2cb3d78de3f4521b9922421f5a8cc096
https://pubmed.ncbi.nlm.nih.gov/34493447
https://pubmed.ncbi.nlm.nih.gov/34493447
Autor:
Hirotoshi Dosaka-Akita, Yohji Itoh, Yutaka Yabuki, Kazumi Nishino, Takayasu Kurata, Junichi Shimizu, Yoko Yoshimura, Haruhiro Saito, Katsuhiro Masago
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 12 (2020)
Therapeutic Advances in Medical Oncology
Therapeutic Advances in Medical Oncology
Background: Molecular diagnostic testing is necessary to guide optimal first-line treatment. The number of patients who receive first-line treatment based on biomarker analysis in Japan is unknown. We aimed to determine the proportion of nonsquamous
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::035e524dba921e9cd006ca8796b37d3d
https://doaj.org/article/6d112c468256484ab90d13d14e14e562
https://doaj.org/article/6d112c468256484ab90d13d14e14e562
Autor:
Ki Rito, Michio Tanaka, Yohji Itoh, Sachiko Kameo, Filip Dubovsky, Raburn M. Mallory, Jing Yu
Publikováno v:
Influenza and Other Respiratory Viruses
Background Quadrivalent live attenuated influenza vaccine (Q/LAIV) has not been assessed in Japanese children. Objectives Evaluate safety and efficacy of Q/LAIV in Japanese children. Patients/methods Two phase 3 studies were conducted in the 2014-201
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::26033d51098057231407c155f46bdb1f
https://doi.org/10.1111/irv.12555
https://doi.org/10.1111/irv.12555
Autor:
Stephen W.L. Lee, Rungroj Krittayaphong, Vo T. Nhan, Yong Huo, Yohji Itoh, Tiong Kiam Ong, Chee Tang Chin, Jitendra P.S. Sawhney, Hyo-Soo Kim, Stephen Jan
Publikováno v:
Bulletin of the World Health Organization
To estimate out-of-pocket costs and the incidence of catastrophic health expenditure in people admitted to hospital with acute coronary syndromes in Asia.Participants were enrolled between June 2011 and May 2012 into this observational study in China
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a4584bf9102297302c4c8ec1c7807431
https://doi.org/10.2471/blt.15.158303
https://doi.org/10.2471/blt.15.158303